Scarica l'app Stockscreener
8.35
1.76%
-0.15
Precedente Chiudi:
$8.50
Aprire:
$8.58
Volume 24 ore:
670.25K
Relative Volume:
1.08
Capitalizzazione di mercato:
$428.66M
Reddito:
$57.94M
Utile/perdita netta:
$-151.18M
Rapporto P/E:
-2.9698
EPS:
-2.8116
Flusso di cassa netto:
$-86.56M
1 W Prestazione:
-5.54%
1M Prestazione:
+1.33%
6M Prestazione:
-20.63%
1 anno Prestazione:
-17.24%
Intervallo 1D:
$8.24
$8.62
Intervallo di 1 settimana:
$8.19
$8.81
Portata 52W:
$7.73
$11.80
Prothena Corp Plc Stock (PRTA) Company Profile
Nome
Prothena Corp Plc
Settore
Industria
Telefono
011-353-1-236-2500
Indirizzo
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Compare PRTA vs VRTX, MRNA, REGN, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRTA
Prothena Corp Plc
|
8.35 | 428.66M | 57.94M | -151.18M | -86.56M | -2.8116 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Prothena Corp Plc Stock (PRTA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-28 | Downgrade | BofA Securities | Neutral → Underperform |
| 2025-05-27 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-05-27 | Downgrade | Jefferies | Buy → Hold |
| 2025-05-27 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-12-20 | Iniziato | Chardan Capital Markets | Buy |
| 2024-01-30 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-12 | Iniziato | Deutsche Bank | Buy |
| 2023-04-24 | Iniziato | SVB Securities | Outperform |
| 2023-01-27 | Iniziato | Piper Sandler | Overweight |
| 2022-11-04 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-28 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-11-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-06-18 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-06-08 | Reiterato | Oppenheimer | Outperform |
| 2021-05-26 | Iniziato | Citigroup | Buy |
| 2021-02-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-02-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-02-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-12-07 | Iniziato | H.C. Wainwright | Buy |
| 2020-07-09 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2019-11-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-05-21 | Downgrade | Barclays | Equal Weight → Underweight |
| 2018-04-23 | Downgrade | Jefferies | Buy → Hold |
| 2018-04-05 | Reiterato | Barclays | Overweight |
| 2017-11-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2017-09-29 | Reiterato | BTIG Research | Buy |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-11 | Iniziato | Jefferies | Buy |
| 2017-04-12 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-04-12 | Iniziato | Piper Jaffray | Overweight |
| 2017-03-02 | Iniziato | Instinet | Buy |
| 2016-12-21 | Iniziato | SunTrust | Buy |
| 2016-11-03 | Iniziato | Deutsche Bank | Buy |
| 2016-08-04 | Reiterato | Barclays | Overweight |
| 2016-05-13 | Iniziato | Barclays | Overweight |
| 2016-02-19 | Reiterato | Wedbush | Outperform |
| 2016-01-21 | Iniziato | Credit Suisse | Outperform |
Mostra tutto
Prothena Corp Plc Borsa (PRTA) Ultime notizie
Form 4 PROTHENA CORP PUBLIC LTD CO For: 11 October By Investing.com - Investing.com Nigeria
Form 4 PROTHENA CORP PUBLIC LTD CO For: 10 October By Investing.com - Investing.com Canada
Form 4 PROTHENA CORP PUBLIC LTD CO For: 10 October By Investing.com - Investing.com India
Form 4 PROTHENA CORP PUBLIC LTD CO For: 10 October By Investing.com - Investing.com South Africa
CRMD vs. PRTA: Which Stock Should Value Investors Buy Now? - Zacks Investment Research
Prothena Director William P. Scully Acquires 100,000 Shares at $8.57 Each - Kalkine Media
Insider Stock Purchases: October 06, 2026 - Quiver Quantitative
A development chief is leaving Prothena (PRTA) to join one of its strategic partners. - stocktitan.net
Prothena Corporation Public Limited Company Announces Resignation of Chad J. Swanson, Ph.D. as Chief Development Officer, Effective October 9, 2026 - marketscreener.com
Form 4 PROTHENA CORP PUBLIC LTD CO For: 1 October By Investing.com - Investing.com Canada
Form 4 PROTHENA CORP PUBLIC LTD CO For: 29 September By Investing.com - Investing.com Nigeria
Form 4 PROTHENA CORP PUBLIC LTD CO For: 29 September By Investing.com - Investing.com Canada
Form 4 PROTHENA CORP PUBLIC LTD CO For: 29 September By Investing.com - Investing.com UK
Form 4 PROTHENA CORP PUBLIC LTD CO For: 27 September - Investing.com India
Insider Stock Purchases: September 24, 2026 - Quiver Quantitative
Prothena Director William P. Scully Acquires 100,000 Shares at Average Price of $8.43 - kalkinemedia.com
Prothena Corp Public Ltd Insider Bought Shares Worth $843,460, According to a Recent SEC Filing - Yahoo Finance
Prothena to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
A biotech company's leaders will speak live in New York Sept. 16 - Stock Titan
Prothena stock holds near USD 9.60 after market cap update - AD HOC NEWS
Prothena Director William P. Scully Acquires 27,000 Shares in Open Market - kalkinemedia.com
Responsive Playbooks and the PRTA Inflection - Stock Traders Daily
Sarissa Capital Management and Alexander J. Denner Hold 25.7 Million Shares in Amarin Corporation (NASDAQ: AMRN) - kalkinemedia.com
Prothena Corporation plc (PRTA) Key Financial Ratios – Valuation, Profitability & More - Value Research
Prothena Stock Price Forecast. Should You Buy PRTA? - StockInvest.us
Prothena Corporation plc (PRTA) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Prothena Corporation plc (PRTA) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Prothena (NASDAQ:PRTA) Major Shareholder Buys 50,000 Shares of Stock - MarketBeat
Prothena (NASDAQ: PRTA) insider lifts direct stake to 800,000 shares - stocktitan.net
Trustee controls a tenth of Prothena (PRTA) stock via trusts - Stock Titan
Prothena (NASDAQ:PRTA) Shares Pass Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Prothena (PRTA) Holds Steady Near $8.88 as Shares Sit Between Key Support and ResistancePositive Gamma - vinanet.vn
Prothena (PRTA) 10% holder logs 963K-share gifts - Stock Titan
Precision Trading with Prothena Corporation Plc (PRTA) Risk Zones - Stock Traders Daily
HC Wainwright Issues Positive Estimate for Prothena Earnings - MarketBeat
Prothena (PRTA) Stock Shrugs Off Revenue Drop As Pipeline Stakes Rise - Sahm
Prothena Corporation PLC (PRTA) Stock News Today - TradingKey
PRTA's Q2 Loss Narrower Than Expected, Pipeline Progress in Focus - tradingview.com
PRTA's Q2 Loss Narrower Than Expected, Pipeline Progress in Focus - Yahoo Finance
Prothena Reports Second Quarter 2026 Financial Results and Business Highlights - BioSpace
Prothena (NASDAQ:PRTA) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
Prothena (PRTA) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Prothena Corporation PLC reports results for the quarter ended June 30Earnings Summary - tradingview.com
Prothena: Q2 Earnings Snapshot - marketscreener.com
Prothena: Q2 Earnings Snapshot - Yahoo Finance
Prothena (NASDAQ: PRTA) turns H1 2026 profit on $50M milestone - Stock Titan
Prothena Reports Second Quarter 2026 Financial Results and Business Highlights - marketscreener.com
Prothena Reports Second Quarter 2026 Financial Results and Business Highlights - Yahoo Finance
FMR LLC discloses 13.8% Prothena (PRTA) ownership; key fund holds 6.4% - stocktitan.net
Renaissance Technologies LLC Has $5.91 Million Stock Position in Prothena Corporation plc $PRTA - MarketBeat
Prothena Corp Plc Azioni (PRTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Prothena Corp Plc Azioni (PRTA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| SCULLY WILLIAM P | 10% Owner |
Oct 14 '26 |
Buy |
8.46 |
10,000 |
84,569 |
1,037,000 |
| SCULLY WILLIAM P | 10% Owner |
Oct 08 '26 |
Buy |
8.57 |
90,000 |
770,904 |
529,000 |
| SCULLY WILLIAM P | 10% Owner |
Oct 07 '26 |
Buy |
8.40 |
125,000 |
1,050,150 |
439,000 |
| SCULLY WILLIAM P | 10% Owner |
Oct 02 '26 |
Buy |
8.57 |
100,000 |
857,240 |
314,000 |
| SCULLY WILLIAM P | 10% Owner |
Sep 29 '26 |
Buy |
8.68 |
162,000 |
1,405,674 |
214,000 |
| SCULLY WILLIAM P | 10% Owner |
Sep 28 '26 |
Buy |
8.60 |
103,500 |
889,872 |
187,000 |
| SCULLY WILLIAM P | 10% Owner |
Sep 18 '26 |
Buy |
8.43 |
100,000 |
843,460 |
927,000 |
| SCULLY WILLIAM P | 10% Owner |
Sep 02 '26 |
Buy |
9.47 |
27,000 |
255,739 |
827,000 |
| SCULLY WILLIAM P | 10% Owner |
Aug 20 '26 |
Buy |
8.79 |
50,000 |
439,430 |
800,000 |
| SCULLY WILLIAM P | 10% Owner |
Aug 07 '26 |
Buy |
8.62 |
3,500 |
30,167 |
83,500 |
4.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):